Wound healing is one of the most complex biological processes to occur in life. Repair of
tissue following injury involves dynamic interactions between multiple cell types, growth …

This review is based on the previous one published in 2010–Secades JJ. Citicoline:
pharmacological and clinical review, 2010 update. Rev Neurol 2011; 52 (Suppl 2): S1-62 …

Purpose To identify the optimal dose of a novel Rho kinase inhibitor, K-115, by assessing
dose dependency of the intraocular pressure (IOP)-lowering effects and the safety in …

Posterior segment eye diseases (PSEDs) including age macular degeneration (AMD) and
diabetic retinopathy (DR) are amongst the major causes of irreversible blindness worldwide …

This review is based on the previous one published in 2010–Secades JJ. Citicoline:
pharmacological and clinical review, 2010 update. Rev Neurol 2011; 52 (Suppl 2): S1-62 …

Glaucoma is the second leading cause of blindness worldwide and is most notably
characterized by progressive optic nerve atrophy and advancing loss of retinal ganglion …

Introduction Glaucoma patients frequently exhibit ocular surface side effects during
treatment with prostaglandin eye drops. The present work investigated whether glaucoma …

The purpose of this study was to characterize and determine the efficacy of a long-term, non-
invasive gel/microsphere (GMS) eye drop for glaucoma. This novel drug delivery system is …

Objectives Glaucoma is characterized by progressive damage of the retinal ganglion cells
(RGCs), resulting in irreversible vision loss. Cannabinoids (CBs) ameliorate several factors …

Glaucoma, a heterogeneous ocular disorder affecting∼ 60 million people worldwide, is
characterized by painless neurodegeneration of retinal ganglion cells (RGCs), resulting in …